Motif Labs Receives Amended Cannabis License from Health Canada
January 11th, 2021
Shipment of Cannabis 2.0 Products to Provinces and Territories Set to Commence in January 2021
Motif Labs (“Motif”), a Licensed Producer (LP) of cannabis products in Canada and leader in cannabinoid extraction, purification, and formulation, today announced it has received an amended license from Health Canada after successfully completing an intensive audit of its internal systems and processes. Through the new license, Motif receives approval from the government of Canada to manufacture and supply finished Cannabis 2.0 products directly to Canada’s provinces and territories including vaporizers, as well as topicals and tinctures. Now authorized to produce and white-label finished products for a growing number of popular brands, nationally, this marks a significant milestone for Motif and is testament not only to the talent within the organization, but their laser-focus on producing high-quality, consistent cannabinoid extractions for LP’s and third-party brands in Canada.
“Following a thorough audit of our operations, processes and activities, the Motif Labs team and I are thrilled to receive this vote of confidence from Health Canada,” said Mario Naric, Founder and CEO at Motif Labs. “This license opens up an additional revenue stream for Motif, and paves the way for us to bring a number of disruptive Cannabis 2.0 brands and products to market. With legal recreational cannabis sales on the rise in Canada, today’s announcement gives us the added flexibility to support this momentum, and to work with brands that are looking to diversify their product portfolio and increase their market share in the industry.”
By registering with the appropriate provincial cannabis regulatory agencies, Motif is now able to list its brand partners’ product SKUs across Canada. Production of a variety of retail cannabis products offered by Motif’s existing portfolio of brand partners is already underway, with plans to begin shipping products across Canada’s provinces and territories in early 2021.
About Motif Labs
Motif Labs is a cannabis and hemp extraction and processing facility located in SW Ontario. Motif operates as a business-to-business enterprise, offering toll processing and contract manufacturing services to other Licensed Producers (LP’s) and 3rd Party Brands. Founded by a team of Scientists and Engineers, Motif prides itself on the core values of integrity, collaboration and quality. The company has quickly established itself as a leader, and trusted partner, in the Canadian cannabis industry. For more information, visit https://motiflabs.ca/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005096/en/
On behalf of Motif Labs
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.